Sort
3,198 grants matching “mrna vaccine”
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases
$2,150,109T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Studies of the SARS-CoV-2 Spike Protein
$2,147,209Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
COVID-19: immune response and systems vaccinology
$2,134,432Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface
$2,119,522Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
$2,099,783Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2023 · AI
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$2,099,464Barton F Haynes · Duke University · U19 · FY2022 · AI
DNA Vaccines
$2,099,304George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Research Project 3: Rapid-Response Roadmap for RNA vaccines
$2,091,310Jesse Hong-Sae Erasmus · Albert Einstein College Of Medicine · U19 · FY2024 · AI
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
$2,079,017Barton F Haynes · Duke University · U19 · FY2018 · AI
Prevention of AIDS
$2,053,144Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
CoVPN 3006: A randomized controlled study to assess SARS-CoV-2 infection, viral shedding, and subsequent potential transmission in university students immunized with Moderna COVID-19 Vaccine
$2,034,708Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,033,275Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2025 · AR
Antigen Processing And Presentation In The Intestine
$2,029,000Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Human T-Cell Responses to Tumor Antigens
$2,027,509Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
Kaiser Washington Vaccine and Treatment Evaluation Unit - DMID 21-0012
$2,014,564Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
The Biology of HIV Infections
$2,004,520Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Rapid Development of Vaccines for Emerging Viruses
$2,000,768Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research
$2,000,000Philip Bradley · Fred Hutchinson Cancer Research Center · S10 · FY2020 · OD
EFRI DCheM: Distributed Ribonucleic Acid (RNA) Manufacturing via Continuous Enzymatic Reaction and Separation in Biphasic Liquid Media
$1,999,998Daeyeon Lee · University Of Pennsylvania · · FY2021 · ENG
CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES
$1,999,997Yang Xu · Luna Innovations, Inc. · N44 · FY2019 · AI
Retrovirus Models of Lymphocyte Transformation/Disease
$1,980,571Michael D Lairmore · Ohio State University · P01 · FY2007 · CA
Retrovirus Models of Cancer
$1,971,061Lee Ratner · Washington University · P01 · FY2025 · CA
Mechanisms of Protection in Live-attenuated AIDS Vaccin*
$1,969,451Christopher Miller · University Of California At Davis · P01 · FY2006 · AI
Development testing of nucleic acid-based vaccine for HIV other indications
$1,950,208Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Project 2 - GMP Manufacturing of mRNA Immunogens
$1,949,407Thomas N Denny · Duke University · U19 · FY2020 · AI